SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Revenue of SOPHiA GENETICS SA (SOPH)
Revenue in 2023 (TTM): $62.37 M
According to SOPHiA GENETICS SA's latest financial reports the company's current revenue (TTM) is $62.37 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of SOPHiA GENETICS SA
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $62.37 M | $42.91 M | $-70,700,000 | $-78,495,000 | $-78,981,000 |
| 2022 | $47.56 M | $31.25 M | $-82,667,000 | $-87,585,000 | $-87,449,000 |
| 2021 | $40.45 M | $25.22 M | $-70,837,000 | $-73,507,000 | $-73,675,000 |
| 2020 | $28.4 M | $17.69 M | $-38,758,000 | $-41,225,000 | $-39,339,000 |
| 2019 | $25.36 M | $17.83 M | $-30,741,000 | $-33,629,000 | $-33,791,000 |